Inogen | INGN - Operating Profit


Inogen reported $-7.79M in Operating Profit for its fiscal quarter ending in September of 2024.





Operating Profit Change Date
Abbott USD 1.85B 399M Mar/2026
Accuray USD 4.71M 6.86M Dec/2024
AngioDynamics USD -2.51M 5.41M Sep/2025
Artivion USD 4.79M 6.85M Dec/2025
AtriCure USD 526K 1.96M Mar/2026
Baxter International USD 66M 280.2M Mar/2026
Becton, Dickinson and Co. USD 627M 36M Mar/2026
Boston Scientific USD 1.05B 190M Mar/2026
Chart Industries USD 52.6M 72.5M Mar/2026
Cooper Companies USD 212.8M 72.4M Dec/2025
Dexcom USD 255.3M 67.7M Mar/2026
Edwards Lifesciences USD 514.7M 144.4M Mar/2026
Globus Medical USD 164M 17.31M Mar/2026
Inogen USD -7.79M 728K Sep/2024
Insulet USD 122M 24.3M Mar/2026
Masimo USD 77.4M 6.5M Mar/2026
Medtronic USD 1.74B 40M Dec/2025
Orthofix International USD 6.12M 1.91M Dec/2025
Philips EUR 302M 417M Mar/2026
ResMed USD 505.67M 8.07M Mar/2026
Steris USD 318.7M 40.7M Mar/2026
Stryker USD 1.1B 867M Mar/2026
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Teleflex USD 37.03M 686K Mar/2026
X T L Biopharmaceuticals USD -812K 48K Dec/2024
Zimmer Biomet Holdings USD 395.1M 92.2M Mar/2026